| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $315,952 ) |
| | 2025 | 2025 | ELLISON INSTITUTE LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064-1016 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 000 | 5 | NIH | 11/5/2024 | $315,952 |
|
| Issue Date FY: 2024 ( Subtotal = $333,481 ) |
| | 2024 | 2024 | ELLISON INSTITUTE LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064-1016 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 000 | 4 | NIH | 11/16/2023 | $315,930 |
| | 2024 | 2024 | ELLISON INSTITUTE LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064-1016 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 001 | 4 | NIH | 4/17/2024 | $17,551 |
|
| Issue Date FY: 2023 ( Subtotal = $344,960 ) |
| | 2023 | 2023 | ELLISON INSTITUTE, LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 002 | 3 | NIH | 3/14/2023 | $28,160 |
| | 2023 | 2023 | ELLISON INSTITUTE, LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 000 | 3 | NIH | 11/21/2022 | $316,800 |
|
| Issue Date FY: 2022 ( Subtotal = $964,112 ) |
| | 2022 | 2022 | ELLISON INSTITUTE, LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 003 | 2 | NIH | 5/23/2022 | $609,080 |
| | 2022 | 2022 | ELLISON INSTITUTE, LLC | 12414 EXPOSITION BLVD | LOS ANGELES | CA | 90064-1016 | LOS ANGELES | USA | R01CA241137 | A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression | 001 | 2 | NIH | 4/12/2022 | $355,032 |
|
|
